Back

TAPSE/sPAP ratio predicts 1-Year mortality in cardiac resynchronization therapy recipients with heart failure background

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Comorbidities and multimorbidity (2) Epidemiology, Prognosis, Outcome Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Fatmanur Oguz

Ankara Etlik City Hospital, Ankara (Turkiye)

5 More presentations in this session

Presentation thumbnail
Baseline demographic and comorbidity burden of patients with supranormal glomerular filtration rate: a distinct phenotype?
Associate Professor S. Unlu (Ankara, TR)
Abstract
Presentation thumbnail
Relationship between NT-proBNP levels and BMI on clinical outcomes in heart failure: attenuation of the obesity paradox at higher disease severity
Doctor M. Yu (Singapore, SG)
Abstract
Presentation thumbnail
Income and education as determinants of hospital utilization but not mortality in heart failure
Miss A. Carrete (Badalona, ES)
Abstract
Presentation thumbnail
Longitudinal trajectories in clinical status and cardiac remodeling across the heart failure spectrum: 12-month evidence from the BRING-UP-3 HF Study
Doctor C. Basile (Stockholm, SE)
Abstract
Presentation thumbnail
Low-activity alerts as a prognostic marker in ICD/CRT
Doctor I. Almeida (Ponta Delgada, PT)
Abstract

Access the full session

Session thumbnail
Comorbidities and multimorbidity (2)

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources